Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FL061
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,355
Award facts
- Contract value 100% obligated
- $32,354.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a competitively procured delivery order to AmerisourceBergen Drug Corp (Cencora, Inc.) on January 28, 2026, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This firm fixed-price delivery order carries a ceiling value of $32,354.90 and is scheduled for completion by January 29, 2026. The contract represents a task order executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at $999.99 million through December 2031 and serves as the primary pharmaceutical supply vehicle for military healthcare programs globally. No set-aside designation was applied to this award, indicating open competition.
AmerisourceBergen, operating through its subsidiary AmerisourceBergen Drug Corp and parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal agencies, particularly the Department of Defense and the Veterans Health Administration. The delivery of RINVOQ, a prescription medication used for treating inflammatory conditions, reflects the company's role as a key supplier of specialized pharmaceutical products across multiple therapeutic domains. The compressed completion timeline of one day from award to delivery date indicates this order fulfills an urgent medical supply requirement for military treatment facilities or related federal healthcare systems supported by the DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FL061?
SPE2DR26FL061 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FL061 worth?
The government has obligated $32,355 on SPE2DR26FL061.
Is contract SPE2DR26FL061 an order under another contract?
Yes. SPE2DR26FL061 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL061 competed?
The extent of competition for SPE2DR26FL061 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award